Event-Driven Stocks

Rani Therapeutics Holdings, Inc.

RANINasdaq

Healthcare · Pharmaceutical Preparations · CA · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 3 good● 3 warning● 2 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$1.6M$1.0M$0$0$2.7M$462,000
Operating income−$38.3M−$53.3M−$66.1M−$63.5M−$51.6M−$16.5M
Net income−$29.7M−$30.0M−$34.0M−$30.6M−$8.3M−$16.7M
Total assets$58.6M$36.6M$57.9M$108.0M$124.2M$79.4M
Total liabilities$17.1M$33.1M$32.5M$34.0M$2.6M$8.0M
Equity$33.0M$2.0M$12.9M$36.9M$47.4M−$113.3M
EPS (diluted)$-0.45$-1.05$-1.33$-1.28$-0.43—
Shares out.66,13828,47625,50523,81719,534—

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−2346.0%
Net margin
−1817.1%
Return on equity
−89.9%
Return on assets
−50.6%
Return on capital (ROCE)
−83.4%
Liabilities / assets
29.2%
Debt / equity
0.52×
Book value / share
$499.11
Revenue growth (YoY)
58.9%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-5.19distress
Accruals / assets
−18.7%clean
Piotroski F-Score
5/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
68
/ 100
Profitability 0Growth 100Catalyst 100Earnings quality 67Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 2 severe● 3 warning● 3 good
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Negative operating cash flow
  • Revenue is growing year-over-year
  • Conservative leverage (liabilities < 50% of assets)
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

Clinical trials

ClinicalTrials.gov · ongoing · next readout first

Interventional studies led by this company. “Readout” is the trial's primary-completion date — an estimate the sponsor reports, not a guarantee.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Insider transactions

SEC Form 4 · most recent
1 acquisitions1 disposals1 open-market buy(s)net +160,334 shares · last 2
InsiderDateTypeSharesPrice
Imran Mir ADirectorOct 23, 2025Buy2.1M$0.60
South Cone Investments Limited Partnership10% ownerOct 20, 2025Sell1.9M$2.41

Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 20268.0M8.4-11.0%
Apr 30, 20268.9M13.6-5.6%
Apr 15, 20269.5M8.2-6.3%
Mar 31, 202610.1M5.8-4.3%
Mar 13, 202610.6M11.8-8.4%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (2)